" "Piper Jaffray Companies Reiterates "$18.00" Price Target for Horizon Pharma PLC (HZNP)

Adjust Comment Print

The hedge fund run by Carl Goldsmith held 213,544 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $3.46M, down from 1.16 million at the end of the previous reported quarter. While for the next 5 years, the growth estimate is 12.9%.

Traders are a little more bearish on shares of the company if you evaluate the rise in short interest. BidaskClub raised shares of Horizon Pharma PLC from a "hold" rating to a "buy" rating in a research report on Saturday, June 24th. It has underperformed by 44.83% the S&P500.The move comes after 7 months negative chart setup for the $2.26B company. Amalgamated Fincl Bank reported 12,314 shares stake. It improved, as 44 investors sold DISCA shares while 196 reduced holdings.

As of the end of the quarter Rhenman & Partners Asset Management Ab had acquired a total of 670,768 shares growing its position 38.3%. The stock rose 1.16% or $0.16 reaching $13.99. (NASDAQ:CEMP), its shares were trading at $3.15 a retreat of $0, on the trading floor. Tahoe Resources Inc (NYSE:TAHO) has declined 23.51% since September 11, 2016 and is downtrending. It has outperformed by 24.43% the S&P500. The firm has "Buy" rating given on Friday, June 17 by Jefferies. Therefore 57% are positive. Barclays Capital maintained the stock with "Overweight" rating in Thursday, October 6 report. The last close places the company's stock about $10.19 off its 52 week high of $50.75 and $3.02 above the 52 week low of $37.54. The firm has "Buy" rating given on Friday, December 16 by Mizuho. RBC Capital Markets upgraded the shares of BA in report on Thursday, July 27 to "Sector Perform" rating. The firm has "Neutral" rating by IBC given on Thursday, January 19. The company has market cap of $276.55 million.

Since May 10, 2017, it had 1 insider buy, and 0 selling transactions for $94,800 activity. GREY MICHAEL G bought 10,000 shares worth $94,800. $862,280 worth of stock was sold by Kleiman Angela L. on Wednesday, May 10.

Chelsea's N'Golo Kante: 'Special' to make Champions League debut
Such a night in Europe's top competition was one reason Kante chose to move from the King Power Stadium to Stamford Bridge. Now it's the beginning, we can not expect to do the same. "We play Arsenal on Sunday and we will give everything to win".

About 6.98M shares traded or 144.06% up from the average. Hyslop Gregory L sold 5,047 shares worth $922,738. Point72 Asia (Hong Kong) Limited holds 22 shares.

The share price of Horizon Pharma, Inc. Next Century Growth Invsts Ltd Liability owns 1.11 million shares for 1.1% of their portfolio. Asanko Gold Inc (NYSEMKT:AKG) was raised too. Next quarter's EPS is estimated at $0.23 with next year's EPS projected to be $1.26. Its up 0.10, from 0.99 in 2016Q3. It also reduced Mondelez Intl Inc (NASDAQ:MDLZ) stake by 185,049 shares and now owns 14,951 shares. 75 funds opened positions while 136 raised stakes. 445.41 million shares or 0.76% more from 442.07 million shares in 2016Q3 were reported. Panagora Asset Management Incorporated holds 278,251 shares. Lazard Asset Mngmt Ltd, a New York-based fund reported 404,004 shares. Proshare Llc reported 134,759 shares. Pennsylvania Communication has 5,509 shares for 0.03% of their portfolio. Bancorpsouth owns 1,335 shares. Silvercrest Asset Mngmt Ltd Liability Corporation has 11,560 shares for 0% of their portfolio. Geode Mngmt Limited Liability Co stated it has 1.37 million shares or 0.01% of all its holdings. Chevy Chase Tru Hldgs Inc holds 0.27% or 800,484 shares in its portfolio. Employees Retirement Association Of Colorado, Colorado-based fund reported 54,198 shares. Orrstown Finance owns 40 shares for 0.01% of their portfolio. Parametric Port Assocs Ltd Liability invested in 102,142 shares. Analysts predict that Horizon Pharma PLC will post $1.09 EPS for the current year. Therefore 47% are positive. Horizon Pharma PLC has a one year low of $9.45 and a one year high of $21.98. The rating was maintained by Mizuho with "Hold" on Monday, August 28. As per Sunday, July 30, the company rating was maintained by Cantor Fitzgerald. The stock of Horizon Pharma PLC (NASDAQ:HZNP) earned "Buy" rating by Mizuho on Tuesday, May 10. BMO Capital Markets initiated the shares of HZNP in report on Wednesday, June 29 with "Outperform" rating. The market capitalization of the company is at $2.29 Billion. If the average volume is low then the liquidity is low which means it is hard to buy or sell the stock as there are fewer buyers or sellers of the stock. North Tide Capital LLC purchased a new stake in shares of Horizon Pharma PLC in the first quarter worth about $10,238,000. Vanguard Group Inc accumulated 2.95 million shares.

Investors sentiment increased to 1.58 in 2016 Q4.

Shares of Horizon Pharma PLC (NASDAQ:HZNP) traded up 1.88% during midday trading on Friday, reaching $14.09. Cornerstone Advisors Inc stated it has 847 shares or 0.01% of all its holdings. Peak6 Investments Lp invested in 23,005 shares. 41,143 are held by Jefferies Gru Ltd Company. Trading volume for Horizon Pharma plc was 3,291K by the end of trading on Tuesday. Raymond James And has invested 0.01% in Horizon Pharma PLC (NASDAQ:HZNP). Deerfield reported 8.96M shares. Paloma Prtnrs Mgmt Co holds 0% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP) for 28,571 shares. Brinker invested in 0.01% or 12,980 shares. Mizuho reissued a "hold" rating and set a $12.00 price objective (up previously from $9.00) on shares of Horizon Pharma PLC in a research note on Monday, August 28th.